Tune Therapeutics
1 follower
With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine. With deep experience and a passionate commitment to exploration and inn... Read more
Org chart
Charles A. Gersbach
Co-Founder, Acting CSO
Derek Jantz
CSO
Zachary Hale
EVP, General Counsel
Georgeta Puscalau
Senior Vice President Quality
Tyler Goodwin
Director/head Of Delivery Technologies (non-viral/viral Vectors/nucleic Acids/cmc/msat)
Jason Dean
Head Of Bioinformatics
Christina Jordan
Senior Director, Intellectual Property
Glenn Murphy
Director Of Communications
Kendra Congdon
Director
Luis Sanchez-Perez
Director Of Preclinical Translation
Nathaniel Lambert
Director - Immunology
Iram Khan
Associate Director
Shannon Grace
Executive Assistant To Chief Executive Officer & Leadership Team
Katherine H.
EA | Project Manger For Co-founder And Chief Financial Officer
Michael P. Hefferan
Director And Head Of In Vivo Pharmacology
Ryan Tam
Scientist, Product Development
